University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.
Invasive fungal infections are common and often lethal. Despite optimal medical care mortality is 20-30% at six weeks and dramatically rises to 80-100% for drug resistant infection.
These infections occur most commonly in the context of leukemia and bone marrow transplantation and often in young patients with otherwise curable disease.
The researchers, led by Professor William Hope from the University’s Antimicrobial Pharmacodynamics and Therapeutics (APT) Group, have characterised the biochemical and physiologic effects (pharmacodynamics) of F901318, which is the lead compound of the new class of drugs termed the ‘orotomides’.
The ‘orotomides’, discovered by F2G Limited, have a novel mechanism of action which is the specific biochemical interaction through which a drug substance produces its pharmacological effect.
This is the first new class of antifungal agent to be discovered in the last three decades.
The study, which was supported by a research grant by F2G, has been published in mBio.
APT’s work provides the underpinning evidence for efficacy and dosage justification for the very first patients receiving the new drug. Such information is required by regulatory agencies such as the European Medicines Agency and the Food and Drug Administration before clinical studies can proceed.
Professor Hope, said: “Antifungal resistance represents a major global clinical challenge. This study provides the necessary information to enable F901318 to be developed for clinical use.”
Learn more: Researchers help develop new antifungal drug
The Latest on: Antifungal drug
- Virginia medical facilities grapple with a new worry — a rise in drug-resistant fungus infectionson May 14, 2021 at 2:55 pm
Called Candida auris, the yeast has been deemed a “serious global health threat” by the U.S. Centers for Disease Control and Prevention thanks to the longevity of its infections and ...
- Horse racing-Kentucky Derby winner Medina Spirit clears final drug test for Preaknesson May 14, 2021 at 2:47 pm
Kentucky Derby-winning horse Medina Spirit will compete in Saturday’s Preakness Stakes after clearing pre-race drug tests, race organisers said on Friday. The Bob Baffert-trained horse tested positive ...
- Horse racing’s drug scandals cheat public and kill horses. Is industry ready to stop?on May 13, 2021 at 11:17 am
The running of the 146th Preakness Stakes at Pimlico Race Course in Baltimore this week will now occur under very disappointing circumstances. Before a single horse has even taken a stride, the second ...
- Black fungus scare: Govt engaging with drug makers to ramp up production of anti-fungal drugon May 12, 2021 at 2:58 am
With a spike in the cases of COVID-19 in the country, doctors have been reporting a rare infection mucormycosis, also called as black fungus, among people recovered from COVID-19. The infection is ...
- Mucormycosis: Centre moves to boost availability of anti-fungal drugon May 12, 2021 at 1:02 am
As more cases of mucormycosis surface across the country, the Centre is proactively engaging with pharmaceutical manufacturers to ramp up production of Amphotericin B, an anti-fungal drug used to ...
- Baffert: Medina Spirit's failed drug test could be linked to anti-fungal ointmenton May 11, 2021 at 4:40 pm
Baffert said he was informed Monday that betamethasone is an ingredient in Otomax, an ointment used on the 3-year-old colt.
- Baffert: Antifungal Meds Given to Medina Spirit Had Steroidon May 11, 2021 at 1:33 pm
Trainer Bob Baffert says Kentucky Derby winner Medina Spirit was treated with an antifungal ointment containing the steroid betamethasone that may have caused the horse to fail a postrace drug test.
- Bob Baffert: Anti-Fungal Ointment Could Explain Medina Spirit's Positive Drug Teston May 11, 2021 at 12:53 pm
In a statement released by Hall of Fame horse trainer Bob Baffert, he alleges that Medina Spirt's positive drug test could be explained by an ointment used to treat dermatitis on the racehorse. Medina ...
- Bob Baffert: Medina Spirit's positive drug test may be result of anti-fungal ointment useon May 11, 2021 at 9:35 am
Bob Baffert added another twist to the Medina Spirit drama on Tuesday. The trainer announced in a statement that Kentucky Derby winner Medina Spirit was treated with an anti-fungal ointment, which ...
- Kentucky Derby winner's trainer - who said the horse was a victim of 'cancel culture' - now says anti-fungal ointment may have caused positive drug teston May 11, 2021 at 9:27 am
Bob Baffert said Medina Spirit had been treated for dermatitis ahead of the race, which he believes may have led to the positive drug test.
via Google News and Bing News